Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
111 participants
INTERVENTIONAL
2022-05-16
2022-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mealtime Symptoms in Dementia
NCT02269956
Optimizing Care for Patients With Dementia
NCT03442322
Environmental Design for Behavioral Regulation in People With Dementia
NCT04555616
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
NCT00255866
Home-delivered Meals for Persons With Dementia: Which Model Delays Nursing Home Placement?
NCT04850781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aims are:
1. Develop, evaluate, and refine OPTIMAL intervention protocol and training materials. We will integrate evidence from literature and our prior work to develop the intervention protocol and training materials, addressing resident mealtime difficulties, targeted PCMC strategies, and establishment of individualized PCMC plans. We will conduct separate focus group interviews of staff and family participants on the acceptability and appropriateness of the intervention protocol and training materials before pilot testing. Data obtained will be used to refine the intervention protocol and training materials before pilot testing.
2. Determine feasibility, fidelity, and usefulness of OPTIMAL. Feasibility on participant identification, recruitment, consent, and retention will be evaluated descriptively. Fidelity will be assessed on a) delivery of treatment (staff attendance to training sessions), b) receipt of treatment (staff knowledge and self-efficacy pre- \& post-training), and c) enactment of treatment skills (staff PCMC\&TCMC behaviors, quality of staff engagement). We will conduct focus group interviews of staff to assess the usefulness of OPTIMAL after T3.
3. Describe resident outcomes (Exploratory). We will measure and describe resident mealtime difficulties, eating performance, intake success rate, body weight, and body mass index using descriptive statistics over time for two treatment groups. Data obtained will inform estimates of effect sizes for a future larger-scale trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Staff
Start participants who enrolled in the study, received the OPTIMAL intervention, and were observed during data collection.
OPTIMAL
A person-centered mealtime care intervention
Resident
Resident participants who were cared in the study site, and received care from the staff participants before and after the OPTIMAL intervention was delivered to staff.
OPTIMAL
A person-centered mealtime care intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OPTIMAL
A person-centered mealtime care intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥ 55 years
* Diagnosed as having ADRD based on medical records
* Identified by NH staff as requiring mealtime assistance
* Having a legally authorized representative (LAR) providing informed written consent
Staffs
* ≥18 years
* English speaking
* A permanent facility employee
* Provide direct mealtime care for a resident participant at least twice a week over the previous month
Families
* ≥18 years
* English speaking
* A family member of the resident who is living at the NH study site at the time of the study
* Having experience of delivering mealtime care to their resident family members
Exclusion Criteria
* Have a documented diagnosis of Parkinson's disease, traumatic brain injury, or swallowing disorder,
* Do not eat orally (e.g., parenteral/IV feedings, feeding tubes)
* Unable to hear or see staff even with glasses and/or hearing aids (e.g., uncorrected visual or hearing impairment)
* Stay in the NH study site for less than 12 weeks at the time of recruitment/consent/assent (e.g., terminally ill receiving hospice services, and/or receiving post-hospital skilled rehabilitation) that may not allow enough time for obtaining consent/assent, and scheduling days for video recording sessions across three-time points (baseline, and 6- and 12- weeks post-baseline)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of Iowa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wen Liu
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liu Wen, PhD
Role: PRINCIPAL_INVESTIGATOR
The University Of Iowa College Of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Iowa Vateran's Home
Marshalltown, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.